Navigation Links
Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide
Date:7/22/2014

OXFORD, England, July 22, 2014 /PRNewswire/ --


Glide Pharma, the pharmaceutical development and device company focused on solid dose formulations of therapeutics and vaccines, today announced that its novel solid formulation of octreotide acetate achieved successful results in a pre-clinical proof-of-concept study comparing it with the currently marketed liquid product (Sandostatin®).  Based on these results, the company intends to transfer the formulation production process to a contract manufacturing organisation (CMO), and to advance Glide octreotide delivered with the needle-free Glide solid dose injector (SDI®) into clinical trials in 2015.

The pre-clinical study compared the pharmacokinetic profile of the most widely used clinical dose of Sandostatin (100 mcg) with that of Glide's octreotide solid dose formulation.  The results demonstrated that there was no statistical difference between the two profiles (p<0.05).  Octreotide products are currently approved for use in the treatment of acromegaly and certain neuroendocrine tumours with the market for immediate release liquid formulations estimated to be in excess of $150 million.

Dr Mark Carnegie-Brown, Glide Pharma's CEO, commented, "These results represent a significant milestone, both in the development of our final clinical formulation for Glide octreotide and of our scale-up capabilities.  Together, these enable us to transfer the formulation manufacturing process to a CMO later in the year.  This progress is mirrored in our device scale-up programme, and as a result we plan to complete an octreotide clinical proof-of-concept study with our Glide SDI® device in 2015."

About Glide Pharma 

Glide Pharma is a pharmaceutical development and device company focused on solid dose formulations of therapeutics and vaccines.  The company's products are based on its p
'/>"/>

SOURCE Glide Pharma
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter
2. Verathon, maker of GlideScope video laryngoscopes, provides free educational DVD to promote best practices in pediatric airway management.
3. Glide Pharma Completes £14.0 Million ($21.4 Million) Fundraising for Scale Up of Drug and Device Manufacturing Processes and Product Development
4. TriReme Medical and Japanese Partner Century Medical, Inc., Receive Shonin Approval for GliderXtreme PTA Catheter in Japan
5. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
6. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
7. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
8. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
9. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
10. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
11. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... NEW YORK , Sept. 30, 2014 ... stage. Growing ageing population and rise in the incidence ... of chronic wounds and in affordability of better quality ... Chinese wound care market. Universal coverage of public health ... products would further stimulate demand. Based on the findings ...
(Date:9/30/2014)... 30, 2014  Based on its recent analysis ... Sullivan recognizes Ventana Medical Systems, Inc. (Ventana), a ... North American Frost & Sullivan Award for Technology ... with a focus on innovation and improving patient ... tissue-based cancer diagnostic solutions for patients worldwide. ...
(Date:9/30/2014)... Passport Health, one of the largest immunizers ... FluFree.com, a website designed to promote, educate about, and ... years, Passport Health has provided its clients with protection ... FluFree.com is designed to address the growing gap between ... who actually chose to get vaccinated. "We ...
Breaking Medicine Technology:China Wound Care Market 2China Wound Care Market 3Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 2Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 3Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 4Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 2Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 3
... WIRE)--May 10, 2007 - An evaluation of the,safety ... the,treatment of vaginal atrophy, a frequent complaint of,postmenopausal ... American,Menopause Society (NAMS). Entitled "The role of local ... women:,2007 position statement of The North American Menopause ...
... Technology Demonstrates Novel,Anti-Inflammatory Properties, New Surfaxin ... Academic,Societies Annual Meeting , WARRINGTON, Pa., ... Discovery,Laboratories, Inc. (Nasdaq:DSCO) announced that new ... novel KL-4 surfactant,(lucinactant) replacement technology were ...
Cached Medicine Technology:New Position Statement from The North American Menopause Society,Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in,Postmenopausal Women 2New Position Statement from The North American Menopause Society,Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in,Postmenopausal Women 3Discovery's KL-4 Surfactant Technology Demonstrates Novel,Anti-Inflammatory Properties 2Discovery's KL-4 Surfactant Technology Demonstrates Novel,Anti-Inflammatory Properties 3Discovery's KL-4 Surfactant Technology Demonstrates Novel,Anti-Inflammatory Properties 4Discovery's KL-4 Surfactant Technology Demonstrates Novel,Anti-Inflammatory Properties 5Discovery's KL-4 Surfactant Technology Demonstrates Novel,Anti-Inflammatory Properties 6
(Date:9/30/2014)... NJ (PRWEB) September 30, 2014 ... and wellness, is opening another new medical specialty practice ... IMA Cardiology will be located within the ... Ziad Abbud and Dr. Isaac Tawfik of American Heart ... N.J. The new practice will offer Integrated Medicine Alliance ...
(Date:9/30/2014)... research team has been awarded a three-year $1.7 ... (NIH) to develop new imaging technologies and data ... how large networks of neurons in the brain ... help researchers identify the precise interactions between millions ... and speaking, and alterations in these interactions that ...
(Date:9/30/2014)... 30, 2014 Elevate , the latest ... better in and out of the gym by providing natural ... the attention of Shane Michaels, prompting an investigative review. ... the reason most people simply just don’t have the ability ... focused at work, getting the motivation to finish a project, ...
(Date:9/30/2014)... 2014 Hospice & Palliative Care ... Celebration” gala, honoring three outstanding individuals for their ... to provide extraordinary and dignified comfort, care and ... or life-limiting illness. , The event was held ... and recognized William (Bill) J. McGuinness, Director of ...
(Date:9/30/2014)... Dr. Karl R.O.S. Johnson, DC, has developed ... care that is dramatically improving the health and lives ... & Nutrition—applies a proprietary, multi-dimensional approach that goes beyond ... of inflammation, neurology of the joint and neurology of ... brain to the spine, to the legs, knees and ...
Breaking Medicine News(10 mins):Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 3
... neuropathy than blood glucose levels, study suggests , , THURSDAY, ... levels of triglyceride fats are at increased risk of ... or damage of nerves that results in numbness, tingling ... researchers say. , A study by U.S. researchers ...
... 2009 In an effort that will contribute ... and the surrounding region, the country,s National Center ... Calidad (CNCC)has attained internationally recognized ISO/IEC 17025:2005 accreditation ... being celebrated today in Lima by the CNCC ...
... NEW YORK, May 21 The Journal of Visual ... on blindness and visual impairment from AFB Press, is now ... access and $65 for a combined print and online subscription."For ... of the field,s literature by keeping professionals and students up-to-date ...
... HealthEast Care System hospitals have agreed to pay ... that the health care facilities submitted false claims ... three hospitals are located in the Minneapolis-St. Paul, ... Paul-based hospitals overcharged Medicare from 2002 to 2007 ...
... According to a new Mayo Clinic study, a history ... challenges facing depressed inpatients. Included are an increase in ... higher incidence rate of personality disorder. Additionally, these victims ... an increase in psychiatric hospitalizations for psychiatric issues. The ...
... May 21 Mayo Clinic researchers have found that ... such as diabetes, depression, asthma or coronary artery disease. ... care claim costs. Specialty care costs (the costs of ... higher for bipolar patients. Results of this review are ...
Cached Medicine News:Health News:High Blood Fats Tied to Diabetic Nerve Loss 2Health News:Medication quality in Peru and region strengthened with official laboratory's accreditation 2Health News:New Reduced Subscription Rate to Leading International Journal on Blindness and Low Vision 2Health News:Minnesota Hospitals to Pay U.S. $2.28 Million to Settle False Claims Act Allegations 2Health News:Specialty Care Costs for Patients With Bipolar Disorder Are Higher Than Diabetes and Other Chronic Diseases 2
Straight shafts with fine pierse type tips. Flat open serrated handle with dull finish....
Straight shafts with two point fixation. Tips separated by 3 mm, each tip has 0.12 mm, 1 x 2 teeth. Wide serrated handle with dull finish....
Straight shafts with micro Pierse type tips. Flat open serrated handle, dull finish....
Straight shafts with 25 degree angled 1.5 mm tips. 4 mm platform with 0.12 mm, 1 x 2 teeth. Wide serrated handle with polished finish....
Medicine Products: